Mostrando 10 resultados de: 11
Filtros aplicados
Subtipo de publicación
Other(11)
Área temáticas
Enfermedades(9)
Farmacología y terapéutica(7)
Ginecología, obstetricia, pediatría, geriatría(3)
Medicina y salud(3)
Fisiología humana(2)
Origen
google(11)
Benralizumab Reduces Asthma Worsening Episodes
OtherAbstract: Rationale: CompEx (Composite Endpoint for Exacerbations) was recently proposed as a novel endpoint oPalabras claves:Autores:Harrison CastroFuentes:googleA Low Exhaled Nitric Oxide Level Excludes a Short-Term Benefit from Inhaled Corticosteroids in Suspected Asthma
OtherAbstract: Rationale: Fractional exhaled nitric oxide (FeNO) is a non-invasive biomarker that has been used toPalabras claves:Autores:Harrison CastroFuentes:googleD21 ASTHMA TREATMENT: GLUCOCORTICOIDS, BIOLOGICALS AND BEYOND: A Randomised, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy Of Oral Azithromycin (500 Mg Od) As …
OtherAbstract: Methods: This UK-based multi-center, randomized, double-blind, placebo-controlled study in adults wiPalabras claves:Autores:Harrison CastroFuentes:googleExacerbation profile and risk factors in a type-2–low enriched severe asthma cohort: a clinical trial to assess asthma exacerbation phenotypes
OtherAbstract: Rationale: The past 25 years have seen huge progress in understanding of the pathobiology of type-2Palabras claves:Autores:Harrison CastroFuentes:googleDifferential Methylation of Plasma Cell Free DNA: A Potential Asthma Biomarker?
OtherAbstract: Rationale Making a correct diagnosis of asthma is difficult. Methacholine testing is only availablePalabras claves:Autores:Harrison CastroFuentes:googleLong-Term Efficacy of Benralizumab in Patients with Severe Asthma Directly Transitioning from the ANDHI Double-Blind to the ANDHI in Practice Open-Label Extension Substudy
OtherAbstract: Rationale: The Phase IIIb, randomized, parallel-group, placebo-controlled ANDHI double-blind (DB) stPalabras claves:Autores:Harrison CastroFuentes:googleTowards clinical remission in severe asthma: An analysis of patients treated with benralizumab in the phase 3b ANDHI trial
OtherAbstract: Rationale: A consensus definition for clinical remission in severe asthma was recently published byPalabras claves:Autores:Harrison CastroFuentes:googleQualitative Research on Patient Experiences of As-Needed Budesonide/Formoterol for Treatment of Mild Asthma
OtherAbstract: RATIONALE: As-needed budesonide/formoterol was recently shown to reduce exacerbation risk in mild asPalabras claves:Autores:Harrison CastroFuentes:googleSTIFLE: an exploratory longitudinal study to characterize daily changes and relationships in airway inflammation, symptoms, lung function, and reliever use in adult asthma patients
OtherAbstract: RATIONALE: Airway inflammation is a key feature of the pathophysiology of asthma. In patients with mPalabras claves:Autores:Harrison CastroFuentes:googlePreventer Therapy for Mild Asthma: A Qualitative Study of Patients' Treatment Experiences
OtherAbstract: RATIONALE: Guidelines recommend that most mild asthma patients should receive inhaled corticosteroidPalabras claves:Autores:Harrison CastroFuentes:google